Agilent Technologies ROA 2010-2025 | A

Current and historical return on assets (ROA) values for Agilent Technologies (A) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Agilent Technologies ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2025-04-30 $1.17B $12.16B 9.94%
2025-01-31 $1.26B $11.91B 11.04%
2024-10-31 $1.29B $11.85B 11.55%
2024-07-31 $1.41B $11.00B 12.97%
2024-04-30 $1.24B $10.86B 11.49%
2024-01-31 $1.24B $10.95B 11.45%
2023-10-31 $1.24B $10.76B 11.50%
2023-07-31 $1.13B $10.68B 10.56%
2023-04-30 $1.35B $10.79B 12.65%
2023-01-31 $1.32B $10.92B 12.48%
2022-10-31 $1.25B $10.53B 12.00%
2022-07-31 $1.33B $10.48B 12.66%
2022-04-30 $1.26B $10.46B 12.03%
2022-01-31 $1.21B $10.33B 11.50%
2021-10-31 $1.21B $10.71B 11.73%
2021-07-31 $0.99B $10.49B 9.85%
2021-04-30 $0.93B $10.40B 9.43%
2021-01-31 $0.81B $9.67B 8.46%
2020-10-31 $0.72B $9.63B 7.54%
2020-07-31 $0.69B $9.55B 7.28%
2020-04-30 $0.68B $9.46B 7.38%
2020-01-31 $0.76B $9.50B 8.35%
2019-10-31 $1.07B $9.45B 11.88%
2019-07-31 $1.07B $8.63B 12.20%
2019-04-30 $1.12B $9.02B 12.82%
2019-01-31 $1.14B $8.95B 13.17%
2018-10-31 $0.32B $8.54B 3.68%
2018-07-31 $0.30B $8.35B 3.48%
2018-04-30 $0.24B $8.78B 2.77%
2018-01-31 $0.20B $8.70B 2.35%
2017-10-31 $0.68B $8.43B 8.40%
2017-07-31 $0.63B $8.26B 7.93%
2017-04-30 $0.58B $8.02B 7.41%
2017-01-31 $0.51B $7.87B 6.56%
2016-10-31 $0.46B $7.79B 6.06%
2016-07-31 $0.48B $7.73B 6.31%
2016-04-30 $0.46B $7.64B 6.24%
2016-01-31 $0.46B $7.30B 6.24%
2015-10-31 $0.40B $7.48B 5.41%
2015-07-31 $0.28B $7.25B 3.36%
2015-04-30 $0.31B $7.41B 3.47%
2015-01-31 $0.37B $7.52B 3.67%
2014-10-31 $0.50B $10.82B 4.64%
2014-07-31 $0.69B $10.38B 6.48%
2014-04-30 $0.71B $11.03B 6.69%
2014-01-31 $0.74B $10.64B 7.02%
2013-10-31 $0.72B $10.69B 6.86%
2013-07-31 $0.94B $10.28B 8.92%
2013-04-30 $1.01B $10.59B 9.76%
2013-01-31 $1.10B $10.65B 10.92%
2012-10-31 $1.15B $10.54B 11.89%
2012-07-31 $1.02B $9.76B 10.90%
2012-04-30 $1.10B $9.41B 12.16%
2012-01-31 $1.05B $9.10B 11.80%
2011-10-31 $1.01B $9.06B 11.73%
2011-07-31 $1.02B $8.75B 11.55%
2011-04-30 $0.89B $8.65B 10.03%
2011-01-31 $0.80B $8.04B 9.22%
2010-10-31 $0.68B $9.70B 8.01%
2010-07-31 $0.42B $9.10B 5.20%
2010-04-30 $0.19B $7.77B 2.61%
2010-01-31 $-0.02B $7.57B -0.23%
2009-10-31 $-0.03B $7.61B -0.44%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $32.827B $6.510B
Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.381B 27.82
Boston Scientific (BSX) United States $149.868B 37.52
Stryker (SYK) United States $143.347B 29.97
EssilorLuxottica (ESLOY) France $128.152B 0.00
Medtronic (MDT) Ireland $110.735B 15.70
Lonza Group Ag (LZAGY) Switzerland $49.273B 0.00
Haleon (HLN) United Kingdom $46.811B 26.69
ResMed (RMD) United States $37.196B 27.94
GE HealthCare Technologies (GEHC) United States $32.638B 15.50
Terumo (TRUMY) Japan $26.398B 34.29
Koninklijke Philips (PHG) Netherlands $21.463B 15.06
Insulet (PODD) United States $21.334B 83.74
Zimmer Biomet Holdings (ZBH) United States $18.048B 11.59
Baxter (BAX) United States $15.390B 11.49
Smith & Nephew SNATS (SNN) United Kingdom $12.627B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.442B 22.42
Lantheus Holdings (LNTH) United States $5.479B 13.82
Prestige Consumer Healthcare (PBH) United States $4.123B 18.42
Perrigo (PRGO) Ireland $3.643B 9.23
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.415B 15.55
Envista Holdings (NVST) United States $3.202B 26.61
ICU Medical (ICUI) United States $3.144B 23.18
GN Store Nord (GNNDY) Denmark $2.272B 18.82
QuidelOrtho (QDEL) United States $1.896B 13.04
LeMaitre Vascular (LMAT) United States $1.848B 41.30
AtriCure (ATRC) United States $1.554B 0.00
Acuren (TIC) United States $1.324B 0.00
AdaptHealth (AHCO) United States $1.132B 11.49
Neogen (NEOG) United States $1.072B 13.72
Green Thumb Industries (GTBIF) United States $1.042B 23.43
BioLife Solutions (BLFS) United States $1.008B 0.00
Phibro Animal Health (PAHC) United States $0.968B 12.37
InMode (INMD) Israel $0.839B 8.46
Kestra Medical Technologies (KMTS) United States $0.772B 0.00
CeriBell (CBLL) United States $0.647B 0.00
Evolus (EOLS) United States $0.598B 0.00
Owens & Minor (OMI) United States $0.567B 4.71
Curaleaf Holdings (CURLF) Canada $0.531B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.525B 0.00
Valneva SE (VALN) France $0.478B 0.00
Surmodics (SRDX) United States $0.415B 0.00
Capricor Therapeutics (CAPR) United States $0.377B 0.00
Tilray Brands (TLRY) Canada $0.362B 0.00
SNDL (SNDL) Canada $0.328B 0.00
VAREX IMAGING (VREX) United States $0.319B 11.74
SEMPERIT AG HLD (SEIGY) Austria $0.307B 0.00
Sanuwave Health (SNWV) United States $0.288B 0.00
Viemed Healthcare (VMD) United States $0.262B 22.07
Cerus (CERS) United States $0.256B 0.00
ZimVie (ZIMV) United States $0.245B 11.13
Sanara MedTech (SMTI) United States $0.242B 0.00
Quanterix (QTRX) United States $0.238B 0.00
Aurora Cannabis (ACB) Canada $0.229B 68.00
Canopy Growth (CGC) Canada $0.228B 0.00
OraSure Technologies (OSUR) United States $0.224B 0.00
Biote (BTMD) United States $0.217B 6.09
Cresco Labs (CRLBF) United States $0.212B 0.00
TriSalus Life Sciences (TLSI) United States $0.212B 0.00
Brainsway (BWAY) Israel $0.206B 54.55
Omeros (OMER) United States $0.188B 0.00
High Tide (HITI) Canada $0.180B 0.00
Utah Medical Products (UTMD) United States $0.174B 14.19
Verano Holdings (VRNOF) United States $0.174B 0.00
Organigram Global (OGI) Canada $0.173B 0.00
Exagen (XGN) United States $0.154B 0.00
Vireo Growth (VREOF) United States $0.132B 0.00
FitLife Brands (FTLF) United States $0.125B 0.00
Jin Medical (ZJYL) China $0.095B 0.00
Veru (VERU) United States $0.091B 0.00
Fonar (FONR) United States $0.088B 11.34
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Quipt Home Medical (QIPT) United States $0.083B 0.00
MacroGenics (MGNX) United States $0.083B 0.00
Agape ATP (ATPC) $0.079B 0.00
TerrAscend (TSNDF) Canada $0.077B 0.00
Apyx Medical (APYX) United States $0.076B 0.00
Zynex (ZYXI) United States $0.075B 0.00
Cytosorbents (CTSO) United States $0.074B 0.00
InterCure (INCR) Israel $0.069B 0.00
ImmuCell (ICCC) United States $0.069B 0.00
Jushi Holdings (JUSHF) United States $0.054B 0.00
Nephros (NEPH) United States $0.053B 71.43
Modular Medical (MODD) United States $0.041B 0.00
United-Guardian (UG) United States $0.038B 12.98
Rockwell Medical (RMTI) United States $0.030B 0.00
Safety Shot (SHOT) United States $0.023B 0.00
INLIF (INLF) $0.019B 0.00
Allurion Technologies (ALUR) United States $0.017B 0.00
Cellectar Biosciences (CLRB) United States $0.016B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.011B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00